Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Open-label Study of Efficacy and Safety of Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis in Colombia.

NCT00471705 is registered in ClinicalTrials.gov with Universidad de Antioquia as lead sponsor.

NCT NCT00471705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Open-label Study of Efficacy and Safety of Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis in Colombia.
Lead sponsor
Universidad de Antioquia
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
December 31, 2009
Enrollment
437 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis